Project Grant K43TW012781
Award Date
9/1/24
Completion Date
8/31/29
Dollars Obligated
$108K
Federal Agency
Fogarty International Center
Federal Grant Program
93.989
Assistance Type
Project Grant
Place of Performance
Uganda
Similar Awards
This $109,704 Project Grant award from the John E. Fogarty International Center (CFDA 93.989 - International Research and Research Training) aims to develop and pilot an implementation strategy for integrating tuberculosis (TB) treatment into community pharmacies in Uganda to improve TB/HIV outcomes. The key products and services to be delivered under this 5-year award to the Infectious Diseases Institute LIMITED (IDI) in Kampala, Uganda include: Exploring barriers and facilitators to...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) totals $1,251,718 and will be executed from September 2024 through June 2029. The primary objectives are to: Determine the impact of HIV co-infection on cardiopulmonary function in individuals who have completed treatment for pulmonary tuberculosis (TB), including assessments of pulmonary function tests, echocardiography, 6-minute walk test,...
This $134,811 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to identify and adapt an intervention to address common mental disorders (CMDs) among people being treated for tuberculosis (TB) in Uganda. The key objectives are to: 1) examine the relationship between CMDs and TB treatment adherence/outcomes to identify critical timing and type of intervention needed, 2) adapt and explore...
This federal Project Grant award of $1,413,007 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports the development and evaluation of a novel CRISPR-based diagnostic tool called CRISPR-TB. The primary goal is to improve the detection and treatment monitoring of tuberculosis (TB) in children under 5 years old, who are at high risk of TB but often lack accurate diagnosis. The University of...
This Project Grant award from the Fogarty International Center (CFDA 93.989) at the National Institutes of Health will provide $559,341 over 5 years to support a research project on tuberculosis (TB) in children under 5 years old in Malawi. The primary awardee is a collaborative research partnership between Henry Ford Health and Michigan State University Health Sciences. The key objectives of the research project are to: 1) evaluate the accuracy of new non-invasive TB diagnostic strategies using...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to optimize the implementation of digital X-ray technology with computer-aided detection (CAD) for community-based tuberculosis (TB) screening in sub-Saharan Africa. The $198,720 grant supports the evaluation of two novel screening strategies: 1) adjusting the CAD abnormality score threshold based on client...
This federal Project Grant award of $743,698 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to characterize the burden, severity, and phenotypic presentation of post-tuberculosis (TB) lung disease (PTLD) and its association with interleukin-6 (IL-6) signaling pathways in TB patients with and without HIV. The award will leverage an ongoing NIAID and Indian government-funded study in India...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to develop a prototype mycobacterium tuberculosis (TB) antigen detection assay. The $1,208,700 award, granted on June 11, 2024, will support the University of California, San Diego (UCSD) in conducting laboratory experiments to standardize the assay, assess its analytical performance, and evaluate its clinical utility. The...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $1,185,782 to the University of Alabama at Birmingham (UAB) to establish a global research resource for studying tuberculosis (TB) in human lung tissue. The key products and services funded under this 5-year award include: (1) conducting pathological, cellular, structural, and genetic analysis of resected active TB and post-mortem...
This Project Grant award from the Fogarty International Center (CFDA 93.989 - International Research and Research Training) provides $749,200.00 in funding to the Regents of the University of Minnesota to establish the Minnesota-Makerere-Mbarara Neuro-Infectious Disease Research Training Consortium in Uganda. The program aims to expand research expertise and build capacity in Uganda related to neuro-infectious diseases, particularly HIV-related cryptococcal meningitis and TB meningitis. The...